Raymond James analyst Brian Peterson lowered the firm’s price target on Doximity (DOCS) to $65 from $83 and keeps an Outperform rating on the shares. Doximity’s Q4 results topped the firm’s model, though with more modest upside than recent quarters and a below consensus outlook for fiscal 2026, the analyst tells investors in a research note. Progress on areas such as the client portal, new products and multi-module buying increase the firm’s confidence in the durable growth rate.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Doximity’s Strong Performance and Strategic Positioning Justify Buy Rating Despite Conservative Revenue Guidance
- Doximity price target lowered to $50 from $71 at Canaccord
- Doximity: Strong Performance Amidst Cautious Outlook Warrants Hold Rating
- Doximity’s Strong Q4 Performance Overshadowed by Cautious FY 2026 Outlook: Hold Rating Maintained
- Doximity Hold Rating: Strong Performance Overshadowed by Policy Uncertainties and Cautious Upsell Momentum